Raajesh Anand

Researcher , AVMC Medical College & Hospitral
  • India
Alexandra Davis

Senior Lecturer in Biomedical Science, De Montfort University

Mj Brown

Principal Scientific Associate, Cancer Research UK Cambridge Institute

Felipe Martínez-Ramírez

Postdoctoral researcher, Institute of Immunology and Experimental Therapy PAS

Dmytro Osynskyi

Surgeon oncologist, MNPO Kyiv city clinical oncological center

Richard Brandwein

CTO, PlanetConnect

Carolina Lucchesi

Principal Scientist , ATCC

Sonja von Aulock

Editor, ALTEX Edition

Michal Lipka

CEO, AlphaSales

ANGILERI Francesca

Associate Professor and PI at CICLY, center for innovation in cancerology of Lyon, UCBL1_HCL

My research is committed to developing a 3D liver model to better understand the secondary effects of anticancer agents. By investigating the link between pharmaco-toxicity and genotype-phenotype interactions, this work aims to improve patient follow-up and advance personalized medical care.
Lonneke Vervelde

Senior Scientist, Royal GD

Ayse Guven

European Market Development Manager, Epithelial Cell Biology, STEMCELL Technologies

Elad Katz

Senior Cell Biologist, U of Dundee

Eduardo Rosa-Molinar, Ph.D.

Scientific Director and Professor of Cell Biology & Physiology and Neuroscience , Washington University in Saint Louis School of Medicine, Saint Louis, Mo.

Süleyman Ergün

Director of the Institute of Anatomy and Cell Biology, University of Würzburg

Mhairi Morris

Senior Lecturer (Exercise Oncology), Loughborough University

My current research interests include understanding the interactions between breast cancer cells and stromal cells in the tumour microenvironment, and how exercise may impinge on these interactions. We created a novel 3D model system for investigating the interactions between mesenchymal stem cells and 3D tumour spheroids, and are now branching into patient-derived organoids and adipocytes to model the obesogenic environment in hormonal breast cancers. 
Meritxell B. Cutrona

Head of Patient-derived Organoids, Gustave Roussy Institute

Hugo Vankelecom

Professor, KU Leuven

Kate

CEO, Cytochroma